Abstract: A mobile terminal including a communication unit configured to communicate with at least one external terminal; a memory configured to store at least a first and second operating system including at least first and second modes, respectively; and a controller configured to execute the first operating system and to activate the first mode corresponding to the first operating system, to display a first information screen on a display unit corresponding to the activated first mode, to receive a switching signal indicating the first mode is to be switched to the second mode, to perform an authentication procedure for authenticating that the first mode can be switched to the second mode, to activate the second mode and deactivate the first mode when the authentication procedure is validly performed, and to display a second information screen on the display unit corresponding to the second mode and that is different than the first information screen.

Abstract: A mobile terminal including a communication unit configured to communicate with at least one external terminal; a memory configured to store at least first and second operating systems including at least first and second modes, respectively; and a controller configured to execute the first operating system and to activate the first mode corresponding to the first operating system, to display a first information screen on a display unit corresponding to the activated first mode, to receive a switching signal indicating the first mode is to be switched to the second mode, to attempt to switch to the second mode based on the received switching signal, and to restrict a specific application executing in the first mode when the second mode is not switched to.

Abstract: Disclosed are a display for a multi-function key pad and an electronic device having the display that have both input and output functions. The display for the multi-function key pad includes an electrophoretic display panel provided with a plurality of display regions arranged in a matrix form with having a non-display region as a boundary, a circuit board provided on the display panel and including a plurality of openings formed on regions corresponding to the display regions and a plurality of keys formed on regions that are outer circumference edges of the openings and correspond to the non-display region, and a pad provided on the circuit board and including a plurality of transparent windows formed on regions corresponding to the openings and a plurality of pressing units formed on regions that are outer circumference edges of the transparent windows and correspond to the keys.

Abstract: Disclosed are isoindolinone derivatives, represented by Chemical Formula 1, having inhibitory activity against T-type calcium channels, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an active ingredient. wherein R1˜R6 are as defined in the specification.

Abstract: Disclosed are cis-2,6-disubstituted tetrahydropyran derivatives represented by Chemical Formula 1 and a preparation method thereof. The tetrahydropyran derivatives can be prepared by Prins-reacting tetrahydropyran derivatives with homopargylicalcohol derivatives in the presence of trimethylsilyltriflate. The tetrahydropyran derivatives with cis-substituents at both C2 and C6 positions of the tetrahydropyran ring are useful as intermediates for use in the synthesis and development of therapeutically effective, naturally occurring compounds. (wherein, R1, R2 and R3 are as defined in the specification.).

Abstract: Provided are a novel 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-7-one compound, a pharmaceutically acceptable salt compound thereof, a method for preparing the compound, and an anticancer pharmaceutical composition including the compound as an effective ingredient.

Abstract: The present invention relates to a novel medicinal use of pyrazolopyrimidine compounds having superior effect as serotonin 5-HT2C receptor ligand thus being useful for the prevention and treatment of central nervous system (CNS) diseases. Accordingly, the pharmaceutical composition comprising pyrazolopyrimidine compounds and their pharmaceutically acceptable salts as active ingredients are useful for the prevention and treatment of serotonin 5-HT2C-related central nervous system diseases such as obesity, depression, anxiety and withdrawal symptoms due to drug abuse.

Abstract: The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.

Abstract: The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder.

Abstract: Disclosed are isoindolinone derivatives, represented by Chemical Formula 1, having inhibitory activity against T-type calcium channels, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an active ingredient. wherein R1˜R6 are as defined in the specification.

Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.

Abstract: Compounds and compositions are provided for treatment, prevention, or amelioration of a variety of medical disorders associated with viral infections and/or cell proliferation. The compounds provided herein are 5-phosphono-pent-2-en-1-yl nucleosides and esters thereof.

Abstract: Disclosed are cis-2,6-disubstituted tetrahydropyran derivatives represented by Chemical Formula 1 and a preparation method thereof. The tetrahydropyran derivatives can be prepared by Prins-reacting tetrahydropyran derivatives with homopargylicalcohol derivatives in the presence of trimethylsilyltriflate. The tetrahydropyran derivatives with cis-substituents at both C2 and C6 positions of the tetrahydropyran ring are useful as intermediates for use in the synthesis and development of therapeutically effective, naturally occurring compounds. (wherein, R1, R2 and R3 are as defined in the specification.

Abstract: Disclosed are a display for a multi-function key pad and an electronic device having the display that have both input and output functions. The display for the multi-function key pad includes an electrophoretic display panel provided with a plurality of display regions arranged in a matrix form with having a non-display region as a boundary, a circuit board provided on the display panel and including a plurality of openings formed on regions corresponding to the display regions and a plurality of keys formed on regions that are outer circumference edges of the openings and correspond to the non-display region, and a pad provided on the circuit board and including a plurality of transparent windows formed on regions corresponding to the openings and a plurality of pressing units formed on regions that are outer circumference edges of the transparent windows and correspond to the keys.

Abstract: A button device having display functionality is disclosed. The display buttons have button mechanisms, which, when depressed actuate a switch, creating a signal detected by electronics for the button device. Each button is configured to display an image, which can be changed by a display driver. Accordingly, the display button device can dynamically change the image associated with each button and can correspondingly change the function of each button.

Abstract: A display for a multi-function keypad and an electronic device including the display. The display for a multi-function keypad includes: a display panel having a plurality of display regions arranged in a matrix pattern and a non-display region surrounding the plurality of display regions; a circuit board on the display panel and including a plurality of openings corresponding to the display regions, and a plurality of keys near peripheral edges of the openings and corresponding to the non-display region; and a pad on the circuit board and including a plurality of transparent windows corresponding to the openings, and a plurality of pressing units near peripheral edges of the transparent windows and corresponding to the plurality of keys.

Abstract: A display for a keypad and an electronic device including the display that can improve a user interface environment and stability of input in which the display for the keypad includes: a display panel having a first display region and second display regions; a circuit board disposed on the display panel and including a first opening corresponding to the first display region, second openings corresponding to the second display regions, and keys formed adjacent to the second openings; a touch panel, formed in the first display region in a shape corresponding to the first display region and arranged to fill the first opening; and a pad disposed on the circuit board and including pressing units formed to correspond to the keys.

Abstract: The present invention relates to a tetrahydrofuran compound having cis substituents, the derivatives thereof and a process for preparing the same, and in particular relates to a dihydrofuran-3-ylidene triflate compound having cis substituents at C2 and C5 positions prepared through Prins-type cyclization using a homopropargylic alcohol derivative as a starting material in the presence of Lewis acid catalyst, a tetrahydrofuran compound having cis substituents at C2, C3 and C5 positions prepared through the hydrolysis of triflate group in the derivatives of the dihydrofuran-3-ylidene triflate compound, and a preparation method thereof. The derivatives and the target tetrahydrofuran compound prepared according to the present invention are hydrofuran compounds with novel structures having cis substituents at C2, C3 and/or C5 positions, which are useful as a derivative for synthesizing drugs such as an antagonist for neurokinin receptor.

Abstract: The present invention relates to 1,3-dioxoisoindole derivatives of Formula (1) or pharmaceutically acceptable salts thereof, a preparation method thereof and use thereof as a T-type calcium channel antagonist, based on the fact that 1,3-dioxoisoindole derivatives of Formula (1) show selective antagonistic activity against T-type calcium channel, thus being effective in treating brain diseases, cardiac diseases and neurogenic pains: wherein R1 is a phenyl or a benzyl group, optionally substituted with a moiety selected from the group consisting of a halogen atom, a C1-C6 alkoxy, a C1-C6 alkyl, and a cyano group; R2 is a heterocyclic group selected from the group consisting of piperidinyl, pyrrolidinyl, morpholinyl, and piperazinyl groups, wherein the heterocyclic group is optionally substituted with a C1-C6 alkyl group; and n is 1 or 2.

Abstract: The present invention relates to 1,3-dioxoisoindole derivatives of Formula (1) or pharmaceutically acceptable salts thereof, a preparation method thereof and use thereof as a T-type calcium channel antagonist, based on the fact that 1,3-dioxoisoindole derivatives of Formula (1) show selective antagonistic activity against T-type calcium channel, thus being effective in treating brain diseases, cardiac diseases and neurogenic pains: wherein R1 is a phenyl or a benzyl group, optionally substituted with a moiety selected from the group consisting of a halogen atom, a C1-C6 alkoxy, a C1-C6 alkyl, and a cyano group; R2 is a heterocyclic group selected from the group consisting of piperidinyl, pyrrolidinyl, morpholinyl, and piperazinyl groups, wherein the heterocyclic group is optionally substituted with a C1-C6 alkyl group; and n is 1 or 2.